Recombinant Human Lactoferrin to Reduce Immune

Project: Research project

Project Details

Description

Recombinant Human Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients
StatusFinished
Effective start/end date6/1/165/31/17

Funding

  • HENNEPIN HEALTHCARE RESEARCH INSTITUTE

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.